BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaviarasi S, Yuba E, Harada A, Krishnan UM. Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia. Journal of Controlled Release 2019;300:22-45. [DOI: 10.1016/j.jconrel.2019.02.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin H, Zhang Y, Dong S, Cai X, Jiang H, Fan Y, Ying K, Du B, Yu P, Yang W. Targeted Therapy of Ischemic Stroke via Crossing the Blood-Brain Barrier Using Edaravone-Loaded Multiresponsive Microgels. ACS Appl Bio Mater 2022. [PMID: 36083038 DOI: 10.1021/acsabm.2c00325] [Reference Citation Analysis]
2 Zhong Y, Zeng X, Zeng Y, Yang L, Peng J, Zhao L, Chang Y. Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases. Nano Today 2022;45:101554. [DOI: 10.1016/j.nantod.2022.101554] [Reference Citation Analysis]
3 Faiz K, Lam FC, Chen J, Kasper EM, Salehi F. The Emerging Applications of Nanotechnology in Neuroimaging: A Comprehensive Review. Front Bioeng Biotechnol 2022;10:855195. [DOI: 10.3389/fbioe.2022.855195] [Reference Citation Analysis]
4 Cui B, Shan Y, Zhang T, Ma Y, Yang B, Yang H, Jiao L, Shan B, Lu J. Crossed cerebellar diaschisis-related supratentorial hemodynamic and metabolic status measured by PET/MR in assessing postoperative prognosis in chronic ischemic cerebrovascular disease patients with bypass surgery. Ann Nucl Med 2022. [PMID: 35788959 DOI: 10.1007/s12149-022-01766-0] [Reference Citation Analysis]
5 Waris A, Ali A, Khan AU, Asim M, Zamel D, Fatima K, Raziq A, Khan MA, Akbar N, Baset A, Abourehab MAS. Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders. Nanomaterials 2022;12:2140. [DOI: 10.3390/nano12132140] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen J, Jin J, Li K, Shi L, Wen X, Fang F. Progresses and Prospects of Neuroprotective Agents-Loaded Nanoparticles and Biomimetic Material in Ischemic Stroke. Front Cell Neurosci 2022;16:868323. [DOI: 10.3389/fncel.2022.868323] [Reference Citation Analysis]
7 Ma N, Li G, Fu X. Protective role of activating transcription factor 3 against neuronal damage in rats with cerebral ischemia. Brain Behav 2022;:e32522. [PMID: 35263513 DOI: 10.1002/brb3.2522] [Reference Citation Analysis]
8 Salarpour S, Barani M, Pardakhty A, Khatami M, Pal Singh Chauhan N. The application of exosomes and Exosome-nanoparticle in treating brain disorders. Journal of Molecular Liquids 2022;350:118549. [DOI: 10.1016/j.molliq.2022.118549] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
9 Lam FC, Salehi F, Kasper EM. Integrating Nanotechnology in Neurosurgery, Neuroradiology, and Neuro-Oncology Practice-The Clinicians' Perspective. Front Bioeng Biotechnol 2022;10:801822. [PMID: 35223783 DOI: 10.3389/fbioe.2022.801822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Parvez S, Kaushik M, Ali M, Alam MM, Ali J, Tabassum H, Kaushik P. Dodging blood brain barrier with "nano" warriors: Novel strategy against ischemic stroke. Theranostics 2022;12:689-719. [PMID: 34976208 DOI: 10.7150/thno.64806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Yuan J, Li L, Yang Q, Ran H, Wang J, Hu K, Pu W, Huang J, Wen L, Zhou L, Jiang Y, Xiong X, Zhang J, Zhou Z. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies. ACS Nano 2021;15:16076-94. [PMID: 34606239 DOI: 10.1021/acsnano.1c04753] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
12 Chen W, Jiang L, Hu Y, Fang G, Yang B, Li J, Liang N, Wu L, Hussain Z. Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review. J Control Release 2021;340:342-60. [PMID: 34695522 DOI: 10.1016/j.jconrel.2021.10.020] [Reference Citation Analysis]
13 Li X, Tian X. The protective effects of Pimavanserin against cerebral ischemia-induced brain injury. Bioengineered 2021;12:7481-94. [PMID: 34605354 DOI: 10.1080/21655979.2021.1978617] [Reference Citation Analysis]
14 Li C, Sun T, Jiang C. Recent advances in nanomedicines for the treatment of ischemic stroke. Acta Pharm Sin B 2021;11:1767-88. [PMID: 34386320 DOI: 10.1016/j.apsb.2020.11.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
15 Yang H, Luo Y, Hu H, Yang S, Li Y, Jin H, Chen S, He Q, Hong C, Wu J, Wan Y, Li M, Li Z, Yang X, Su Y, Zhou Y, Hu B. pH-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles for Improved Angiogenesis and Neurological Function Recovery in Ischemic Stroke. Adv Healthc Mater 2021;10:e2100028. [PMID: 34028998 DOI: 10.1002/adhm.202100028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Perrelli A, Fatehbasharzad P, Benedetti V, Ferraris C, Fontanella M, De Luca E, Moglianetti M, Battaglia L, Retta SF. Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM). Expert Opin Drug Deliv 2021;18:849-76. [PMID: 33406376 DOI: 10.1080/17425247.2021.1873273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Almalki WH, Alghamdi S, Alzahrani A, Zhang W. Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges. Drug Discov Today 2021;26:826-35. [PMID: 33383212 DOI: 10.1016/j.drudis.2020.12.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Meng H, Jin W, Yu L, Xu S, Wan H, He Y. Protective effects of polysaccharides on cerebral ischemia: A mini-review of the mechanisms. Int J Biol Macromol 2021;169:463-72. [PMID: 33347928 DOI: 10.1016/j.ijbiomac.2020.12.124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 M Tóth O, Menyhárt Á, Frank R, Hantosi D, Farkas E, Bari F. Tissue Acidosis Associated with Ischemic Stroke to Guide Neuroprotective Drug Delivery. Biology (Basel) 2020;9:E460. [PMID: 33322264 DOI: 10.3390/biology9120460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Sarmah D, Banerjee M, Datta A, Kalia K, Dhar S, Yavagal DR, Bhattacharya P. Nanotechnology in the diagnosis and treatment of stroke. Drug Discov Today 2021;26:585-92. [PMID: 33242696 DOI: 10.1016/j.drudis.2020.11.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Zhou Z, Dun L, Wei B, Gan Y, Liao Z, Lin X, Lu J, Liu G, Xu H, Lu C, An H. Musk Ketone Induces Neural Stem Cell Proliferation and Differentiation in Cerebral Ischemia via Activation of the PI3K/Akt Signaling Pathway. Neuroscience 2020;435:1-9. [DOI: 10.1016/j.neuroscience.2020.02.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
22 Guzman A, Brown F, Acatitla E. Conditional factors Pushing catch-up across developed and emerging countries in the nanotechnology sector, 2000–2010. Economics of Innovation and New Technology 2020;29:670-88. [DOI: 10.1080/10438599.2020.1715059] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tapeinos C, Battaglini M, Marino A, Ciofani G. Smart diagnostic nano-agents for cerebral ischemia. J Mater Chem B 2020;8:6233-51. [DOI: 10.1039/d0tb00260g] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Cui B, Zhang T, Ma Y, Chen Z, Ma J, Ma L, Jiao L, Zhou Y, Shan B, Lu J. Simultaneous PET-MRI imaging of cerebral blood flow and glucose metabolism in the symptomatic unilateral internal carotid artery/middle cerebral artery steno-occlusive disease. Eur J Nucl Med Mol Imaging 2020;47:1668-77. [PMID: 31691843 DOI: 10.1007/s00259-019-04551-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]